Table of contents
Volume 96, Issue 10
Published online 15 May 2007 (1493-1624)
Clinical Studies |
Translational Therapeutics |
Molecular Diagnostics |
Genetics and Genomics |
Letters to the Editor
Reviews
What can we learn from geographical comparisons of childhood cancer survival? FREE
K Pritchard-Jones and C Stiller on behalf of the Children's Cancer and Leukaemia Group (CCLG)
Br J Cancer 96: 1493-1497; advance online publication, April 17, 2007; doi:10.1038/sj.bjc.6603749
How to evaluate the risk/benefit of trimodality therapy in locally advanced non-small-cell lung cancer FREE
H Kunitoh and K Suzuki
Br J Cancer 96: 1498-1503; advance online publication, May 1, 2007; doi:10.1038/sj.bjc.6603751
Clinical Studies
Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients FREE
E de Azambuja, F Cardoso, G de Castro Jr, M Colozza, M S Mano, V Durbecq, C Sotiriou, D Larsimont, M J Piccart-Gebhart and M Paesmans
Br J Cancer 96: 1504-1513; advance online publication, April 24, 2007; doi:10.1038/sj.bjc.6603756
A phase II study of biweekly dose-intensified oral capecitabine plus irinotecan (bXELIRI) for patients with advanced or metastatic gastric cancer FREE
S C Oh, H Y Sur, H J Sung, I K Choi, S S Park, J H Seo, Y T Jeen, H J Chun, S W Shin, Y J Mok, J S Kim and Y H Kim
Br J Cancer 96: 1514-1519; advance online publication, May 1, 2007; doi:10.1038/sj.bjc.6603752
Translational Therapeutics
Combination treatment with Grb7 peptide and Doxorubicin or Trastuzumab (Herceptin) results in cooperative cell growth inhibition in breast cancer cells FREE
S C Pero, G S Shukla, M M Cookson, S Flemer Jr and D N Krag
Br J Cancer 96: 1520-1525; advance online publication, April 10, 2007; doi:10.1038/sj.bjc.6603732
Effect of zoledronic acid on the doxycycline-induced decrease in tumour burden in a bone metastasis model of human breast cancer FREE
W C M Duivenvoorden, S Vukmirovi
-Popovi, M Kalina, E Seidlitz and G Singh
Br J Cancer 96: 1526-1531; advance online publication, April 17, 2007; doi:10.1038/sj.bjc.6603740
The novel microtubule-interfering agent TZT-1027 enhances the anticancer effect of radiation in vitro and in vivo FREE
Y Akashi, I Okamoto, M Suzuki, K Tamura, T Iwasa, S Hisada, T Satoh, K Nakagawa, K Ono and M Fukuoka
Br J Cancer 96: 1532-1539; advance online publication, May 1, 2007; doi:10.1038/sj.bjc.6603769
Molecular Diagnostics
Bcl-2 expression in rituximab refractory cutaneous B-cell lymphoma FREE
M Wobser, H Voigt, A O Eggert, R Houben, C S Kauczok, E B Bröcker and J C Becker
Br J Cancer 96: 1540-1543; advance online publication, May 1, 2007; doi:10.1038/sj.bjc.6603762
Heparan sulphate synthetic and editing enzymes in ovarian cancer FREE
A C Backen, C L Cole, S C Lau, A R Clamp, R McVey, J T Gallagher and G C Jayson
Br J Cancer 96: 1544-1548; advance online publication, April 17, 2007; doi:10.1038/sj.bjc.6603747
BRAF V600E mutation in anaplastic thyroid carcinomas and their accompanying differentiated carcinomas FREE
T Takano, Y Ito, M Hirokawa, H Yoshida and A Miyauchi
Br J Cancer 96: 1549-1553; advance online publication, April 24, 2007; doi:10.1038/sj.bjc.6603764
Human papillomavirus in high- and low-risk areas of oesophageal squamous cell carcinoma in China FREE
K Shuyama, A Castillo, F Aguayo, Q Sun, N Khan, C Koriyama and S Akiba
Br J Cancer 96: 1554-1559; advance online publication, April 24, 2007; doi:10.1038/sj.bjc.6603765
The role of versican isoforms V0/V1 in glioma migration mediated by transforming growth factor-
2 FREE
F Arslan, A-K Bosserhoff, T Nickl-Jockschat, A Doerfelt, U Bogdahn and P Hau
Br J Cancer 96: 1560-1568; advance online publication, April 24, 2007; doi:10.1038/sj.bjc.6603766
Alteration of the serum levels of the epidermal growth factor receptor and its ligands in patients with non-small cell lung cancer and head and neck carcinoma FREE
Y Lemos-González, F J Rodríguez-Berrocal, O J Cordero, C Gómez and M Páez de la Cadena
Br J Cancer 96: 1569-1578; advance online publication, April 24, 2007; doi:10.1038/sj.bjc.6603770
Genetics and Genomics
WTH3 is a direct target of the p53 protein FREE
K Tian, Y Wang and H Xu
Br J Cancer 96: 1579-1586; advance online publication, April 10, 2007; doi:10.1038/sj.bjc.6603724
In silico mining identifies IGFBP3 as a novel target of methylation in prostate cancer FREE
A S Perry, B Loftus, R Moroose, T H Lynch, D Hollywood, R W G Watson, K Woodson and M Lawler
Br J Cancer 96: 1587-1594; advance online publication, April 24, 2007; doi:10.1038/sj.bjc.6603767
Non-genomic action of resveratrol on androgen and oestrogen receptors in prostate cancer: modulation of the phosphoinositide 3-kinase pathway FREE
D A Benitez, E Pozo-Guisado, M Clementi, E Castellón and P M Fernandez-Salguero
Br J Cancer 96: 1595-1604; advance online publication, May 8, 2007; doi:10.1038/sj.bjc.6603755
Patients with an unexplained microsatellite instable tumour have a low risk of familial cancer FREE
L I H Overbeek, C M Kets, K M Hebeda, D Bodmer, E van der Looij, R Willems, M Goossens, N Arts, H G Brunner, J H J M van Krieken, N Hoogerbrugge and M J L Ligtenberg
Br J Cancer 96: 1605-1612; advance online publication, April 24, 2007; doi:10.1038/sj.bjc.6603754
Expression of eEF1A2 is associated with clear cell histology in ovarian carcinomas: overexpression of the gene is not dependent on modifications at the EEF1A2 locus FREE
V A L Tomlinson, H J Newbery, J H Bergmann, J Boyd, D Scott, N R Wray, G C Sellar, H Gabra, A Graham, A R W Williams and C M Abbott
Br J Cancer 96: 1613-1620; advance online publication, April 17, 2007; doi:10.1038/sj.bjc.6603748
Letters to the Editor
The classification of p53 immunohistochemical staining results and patient outcome in ovarian cancer FREE
H Lassus and R Butzow
Br J Cancer 96: 1621-1622; advance online publication, April 17, 2007; doi:10.1038/sj.bjc.6603741
Reply: The classification of p53 immunohistochemical staining results and patient outcome in ovarian cancer FREE
P de Graeff, J Hall, A P G Crijns, G H de Bock, J Paul, K A ten Hoor, S de Jong, H Hollema, J M S Bartlett, R Brown and A G J van der Zee
Br J Cancer 96: 1623-1624; advance online publication, April 17, 2007; doi:10.1038/sj.bjc.6603742
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
